OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 02, 2021
Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.
February 01, 2021
The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.
June 29, 2020
Enhanced sensitivity and ultra-high detection speed provide improved robustness and operability.
October 31, 2019
The company is expanding its bioanalytical capacity and capabilities to support biologic drug development, cell and gene therapy development, and biomarker analysis.
August 02, 2019
Instrumentation advancements over the past 30 years have certainly enabled greater efficiency in pharma development and analysis despite slow adoption by the industry.
June 02, 2019
Excipients and new processing techniques can make a real difference in the development of highly potent therapies.
May 31, 2019
Knauer has introduced new columns and screening services for the enantioseparation of chiral substances.
April 12, 2019
The companies will join forces on a research project to develop end-to-end workflows for the preparation, characterization, and monitoring of biotherapeutics using liquid chromatography-mass spectrometry.
April 02, 2019
Tosoh Bioscience’s LenS3 Multi-Angle Light Scattering (MALS) detector offers a new approach for measuring molecular weight (MW) and radius of gyration (Rg) of synthetic polymers, polysaccharides, proteins, and biopolymers.
March 25, 2019
Waters debuted a range of new TA Instruments innovations and the BioAccord System at Pittcon 2019 in Philadelphia, PA, on March 17–21, 2019.